| P2093 | author name string | Michael D Taylor | |
| | Yuan Yao | |
| | Stephen C Mack | |
| P2860 | cites work | Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade | Q48421918 |
| | Malignant ependymomas in a patient with Turcot's syndrome: case report and management guidelines | Q48507989 |
| | Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma | Q48583497 |
| | Loss of heterozygosity on chromosome 22 in human ependymomas | Q48655553 |
| | p14ARF protein (FL-132) immunoreactivity in intracranial ependymomas and its prognostic significance: an analysis of 103 cases | Q48767123 |
| | Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1. | Q48799635 |
| | Identification of novel regions of allelic loss in ependymomas by high-resolution allelotyping with 384 microsatellite markers | Q48805667 |
| | Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma | Q48818512 |
| | Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray | Q48895739 |
| | Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood | Q48948841 |
| | Differentiation of radial glia from radial precursor cells and transformation into astrocytes in the developing rat spinal cord | Q49093278 |
| | Ependymomas produced after Intracerebral Inoculation of SV40 into New-born Hamsters | Q51293887 |
| | Brain tumors provide new clues to the source of cancer stem cells: does oncology recapitulate ontogeny? | Q52031328 |
| | Change in neurocognitive functioning after treatment with cranial radiation in childhood. | Q52093565 |
| | Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas. | Q52544855 |
| | Epigenetic inactivation of MCJ (DNAJD1) in malignant paediatric brain tumours. | Q53849621 |
| | Multiple ependymomas in a patient with Turcot's syndrome. | Q54574915 |
| | Long-term outcome in patients harboring intracranial ependymoma. | Q55471119 |
| | Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma. | Q55471199 |
| | Aberrant CpG island methylation of multiple genes in ependymal tumors. | Q55472227 |
| | A family with spinal anaplastic ependymoma: evidence of loss of chromosome 22q in tumor | Q55472520 |
| | Functional evaluation of p53 and PTEN gene mutations in gliomas. | Q55475014 |
| | Infrequent alterations of the p15, p16, CDK4 and cyclin D1 genes in non-astrocytic human brain tumors. | Q55479631 |
| | Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3 | Q56673183 |
| | Brain tumors in children | Q72827847 |
| | A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation | Q73785082 |
| | The dual-specificity phosphatase hYVH1 interacts with Hsp70 and prevents heat-shock-induced cell death | Q79760883 |
| | Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysis | Q21136141 |
| | Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins | Q22253159 |
| | GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas | Q24314858 |
| | Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. | Q24533236 |
| | Familial anaplastic ependymoma: evidence of loss of chromosome 22 in tumour cells | Q24562845 |
| | Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma | Q24646111 |
| | Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma | Q24652909 |
| | Telomere maintenance and dysfunction predict recurrence in paediatric ependymoma | Q24652958 |
| | Stem cells of ependymoma | Q24653517 |
| | Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective | Q24658389 |
| | Microarray analysis of pediatric ependymoma identifies a cluster of 112 candidate genes including four transcripts at 22q12.1-q13.3 | Q24683906 |
| | Polycomb CBX7 has a unifying role in cellular lifespan | Q28188425 |
| | Radial glia: multi-purpose cells for vertebrate brain development | Q28215679 |
| | Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group | Q28277811 |
| | mVH1, a dual-specificity phosphatase whose expression is cell cycle regulated | Q28594592 |
| | Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia | Q29614269 |
| | Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2. | Q30486834 |
| | A sequence-ready 840-kb PAC contig spanning the candidate tumor suppressor locus DBC1 on human chromosome 9q32-q33. | Q30646710 |
| | Ependymomas | Q30784966 |
| | Ependymoma: new therapeutic approaches including radiation and chemotherapy | Q31008102 |
| | SV40 and human cancer: a review of recent data | Q31080786 |
| | Absence of simian virus 40 in human brain tumors from northern India | Q33184266 |
| | Karyotype studies in 18 ependymomas with literature review of 107 cases | Q33718650 |
| | Chemotherapy for intracranial ependymomas | Q33768058 |
| | Bioactive lysophospholipids and their G protein-coupled receptors | Q33783568 |
| | Epidemiologic impact of children with brain tumors | Q33797772 |
| | Cross-species genomics matches driver mutations and cell compartments to model ependymoma | Q34031780 |
| | Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma | Q34085362 |
| | Telomerase inhibition as a novel therapy for pediatric ependymoma | Q34100625 |
| | Merlin expression in pediatric anaplastic ependymomas real time PCR study | Q34123623 |
| | Stereotactic radiosurgery for pediatric recurrent intracranial ependymomas | Q34147267 |
| | ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. | Q34153957 |
| | Complex cytogenetic abnormalities including telomeric associations and MEN1 mutation in a pediatric ependymoma. | Q34167470 |
| | Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas | Q34346357 |
| | Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression | Q34364265 |
| | Tumor suppressive role of a 2.4 Mb 9q33-q34 critical region and DEC1 in esophageal squamous cell carcinoma. | Q34373674 |
| | Low expression but infrequent genomic loss of the putative tumour suppressor DBCCR1 in astrocytoma. | Q34383488 |
| | Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas | Q34404481 |
| | Cancer risk associated with receipt of vaccines contaminated with simian virus 40: epidemiologic research | Q34418391 |
| | Contamination of poliovirus vaccines with simian virus 40 (1955-1963) and subsequent cancer rates. | Q34454672 |
| | Radial glia cells are candidate stem cells of ependymoma | Q34459796 |
| | Low incidence of SV40-like sequences in ependymal tumours | Q34464345 |
| | Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma | Q34507174 |
| | Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma | Q34512893 |
| | Current management of childhood ependymoma. | Q34729150 |
| | Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma | Q34733808 |
| | Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas. | Q34760236 |
| | Real-time quantitative PCR analysis of pediatric ependymomas identifies novel candidate genes including TPR at 1q25 and CHIBBY at 22q12-q13. | Q34802431 |
| | The RB and p53 pathways in cancer | Q34804764 |
| | Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. | Q34963365 |
| | Pediatric ependymoma: biological perspectives. | Q34987227 |
| | Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups | Q35746432 |
| | Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups | Q35748208 |
| | Epidemiology of brain tumors in childhood--a review | Q35864296 |
| | A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro-Oncologia. | Q36136815 |
| | Notch signalling in vertebrate neural development | Q36374960 |
| | Familial intracranial ependymomas. Report of three cases in a family and review of the literature | Q36387796 |
| | Genetic abnormalities detected in ependymomas by comparative genomic hybridisation | Q36623735 |
| | The RASSF1A tumor suppressor | Q36945316 |
| | Nucleolus, ribosomes, and cancer | Q37201211 |
| | The genetic and epigenetic basis of ependymoma. | Q37523394 |
| | Histology and molecular pathology of pediatric brain tumors | Q37617838 |
| | Brain cancer propagating cells: biology, genetics and targeted therapies | Q37627436 |
| | A complex karyotype including a t(2;11) in a paediatric ependymoma: case report and review of the literature. | Q37672406 |
| | Radial glia give rise to adult neural stem cells in the subventricular zone | Q37713992 |
| | Ependymomas in adults | Q37738142 |
| | Immune gene and cell enrichment is associated with a good prognosis in ependymoma. | Q38508351 |
| | Expression profiling of ependymomas unravels localization and tumor grade-specific tumorigenesis | Q38509851 |
| | Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). | Q39600883 |
| | Deleted in Esophageal Cancer 1(DEC1) is down-regulated and contributes to migration in head and neck squamous cell carcinoma cell lines | Q39639951 |
| | Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas: a microsatellite analysis | Q39979300 |
| | Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells | Q40677575 |
| | The molecular biology of ependymomas | Q40898736 |
| | Natural simian virus 40 strains are present in human choroid plexus and ependymoma tumors. | Q41290256 |
| | Thioredoxin-1 phosphorylated at T100 is needed for its anti-apoptotic activity in HepG2 cancer cells | Q42974664 |
| | EDG3 and SHC3 on chromosome 9q22 are co-amplified in human ependymomas. | Q43277539 |
| | Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy | Q44085466 |
| | Ependymal tumors | Q44240717 |
| | Adult ependymal cells are postmitotic and are derived from radial glial cells during embryogenesis. | Q45213360 |
| | Papillary ependymomas produced in Rattus (Mastomys) natalensis inoculated with vacuolating virus (SV40). | Q45716303 |
| | DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood | Q45880317 |
| | Molecular staging of intracranial ependymoma in children and adults | Q46526605 |
| | Analysis of HIC-1 methylation and transcription in human ependymomas | Q47661471 |
| | Detection of SV40 T antigen genome in human gliomas | Q47966943 |
| | 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases | Q48138030 |
| | Human ependymomas reveal frequent deletions on chromosomes 6 and 9. | Q48235873 |
| | Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas | Q48258599 |
| | Intracranial ependymoma associated with multiple endocrine neoplasia type 1. | Q48315006 |
| | Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. | Q48364922 |
| | The role of chemotherapy in newly diagnosed ependymoma of childhood | Q48398161 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported | Q15643954 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P921 | main subject | neuroglia | Q177105 |
| | brain tumor | Q233309 |
| | chromosome abnormality | Q744962 |
| | ependymoma | Q1346753 |
| | gene expression profiling | Q1502169 |
| | pediatric ependymoma | Q7159224 |
| | genetic epigenesis | Q64443099 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 669-681 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | Chinese Journal of Cancer | Q15760211 |
| P1476 | title | Molecular genetics of ependymoma | |
| P478 | volume | 30 | |